Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence

Abstract excerpt

). Subsequent functional validation resulted in a markedly diminished in vitro proliferation, self-renewal, and longevity of MB cells, translating into extended survival and reduced tumor burden in vivo. Targeting endothelial nitric oxide synthase, a downstream substrate of BPIFB4, impeded growth of several patient-derived MB lines at low nanomolar concentrations.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Caveolin-1 and cellular processes
• Share to Glioma Diagnosis and Treatment
• Share to Protein Degradation and Inhibitors